PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lithium hydroxide, monohydrate | 603-454-3 | 1310-66-3 | - | - | - | - | 1 | - | - | - | - | Details |
| Lithium hypochlorite | 237-558-1 | 13840-33-0 | - | - | - | - | 1 | - | - | - | - | Details |
| Lithium isopropoxide | 424-140-0 | 2388-10-5 | - | - | - | - | 1 | - | - | - | - | Details |
| Lithium methanolate | 212-737-7 | 865-34-9 | - | - | - | - | 1 | - | - | - | - | Details |
| Lithium nitrate | 232-218-9 | 7790-69-4 | - | - | - | - | 1 | - | - | - | - | Details |
| Lithium perchlorate | 232-237-2 | 7791-03-9 | - | - | - | - | 1 | - | - | - | - | Details |
| Lithium phosphorodifluoridate | 643-080-8 | 24389-25-1 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Lithium salicylate | 209-011-7 | 552-38-5 | - | - | - | - | 1 | - | - | - | - | Details |
|
Lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate
REACTIVE BLUE FC 05 717
|
401-560-2 | 108624-00-6 | - | - | - | - | 1 | - | - | - | - | Details |
| Lithium sulfate monohydrate | 600-157-0 | 10102-25-7 | - | - | - | - | 1 | - | - | - | - | Details |